GlaxoSmithKline plc (NYSE:GSK) stock gained approximately 4% during pre-market hours today, after the company disclosed financial results for fourth quarter of fiscal year 2015 (4QFY15) and fiscal year 2015 (FY15).
GlaxoSmithKline plc (ADR) (NYSE:GSK) may be in for some major restructuring. Neil Woodford, a veteran UK fund manager who holds the company in his equity income fund, is calling for a four-way split of GSK's operations, as per a latest report.
In the Big Pharma space, there are plenty of high-yield stocks out there that are ripe for the picking. Two in particular that investors should consider are AbbVie (NYSE:ABBV) and an international pharmaceutical giant, GlaxoSmithKline (NYSE:GSK).